September 17, 2014 Issue of JAMA

糖心vlog

September 17, 2014, Vol 312, No. 11, Pages 1073-1167

This Week in JAMA

Highlights

Abstract Full Text

free access has audio

JAMA. 2014;312(11):1073-1075. doi:10.1001/jama.2013.279725

Podcast: Antenatal magnesium and school-age outcomes for preterm infants, LABA-ICS vs LABA alone for COPD, treatment of VTE and high cholesterol, and more.

Original Investigation

School-age Outcomes of Very Preterm Infants After Antenatal Treatment With Magnesium Sulfate vs Placebo

Lex W. Doyle, MD, MSc; Peter J. Anderson, PhD; Ross Haslam, MBBS; et al.

Abstract Full Text

free access

JAMA. 2014;312(11):1105-1113. doi:10.1001/jama.2014.11189

This follow-up study to a randomized trial determined that antenatal magnesium sulfate was not associated with improved neurological, cognitive, academic, or behavioral outcomes at school age.

Combination Long-Acting 尾-Agonists and Inhaled Corticosteroids Compared With Long-Acting 尾-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease

Andrea S. Gershon, MD, MSc; Michael A. Campitelli, MPH; Ruth Croxford, MSc, PStat; et al.

Abstract Full Text

free access has multimedia has audio

JAMA. 2014;312(11):1114-1121. doi:10.1001/jama.2014.11432

Gershon and coauthors conducted a population-based, longitudinal cohort study to estimate the long-term benefits of combination long-acting 尾-agonists (LABAs) and inhaled corticosteroids compared with LABAs alone among patients with chronic obstructive pulmonary disease. Calverley comments in an Editorial.

Podcast: Combination Long-Acting 脽-Agonists and Inhaled Corticosteroids Compared With Long-Acting 脽-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease

Editorial
Treating COPD in the Real World
Peter M. A. Calverley, MBChB, DSc

JAMA

Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism: A Systematic Review and Meta-analysis

Lana A. Castellucci, MD; Chris Cameron, MSc; Grégoire Le Gal, MD, PhD; et al.

Abstract Full Text

free access has audio

JAMA. 2014;312(11):1122-1135. doi:10.1001/jama.2014.10538

This systematic review found that low-molecular-weight heparin combined with vitamin K antagonist did not differ in safety or efficacy from most treatment strategies; however, rivaroxaban and apixaban were associated with the lowest risk of bleeding.

Podcast: Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism: A Systematic Review and Meta-analysis

Research Letter

Trends in Mean Waist Circumference and Abdominal Obesity Among US Adults, 1999-2012

Earl S. Ford, MD, MPH; Leah M. Maynard, PhD; Chaoyang Li, MD, PhD

Abstract Full Text

free access

JAMA. 2014;312(11):1151-1153. doi:10.1001/jama.2014.8362

Viewpoint

Population-Based Screening for BRCA1 and BRCA2: 2014 Lasker Award

Mary-Claire King, PhD; Ephrat Levy-Lahad, MD; Amnon Lahad, MD, MPH

Abstract Full Text

free access

JAMA. 2014;312(11):1091-1092. doi:10.1001/jama.2014.12483

This Viewpoint describes the application of the discovery of BRCA1 and discusses screening for BRCA1/2 in clinical practice.

Discovery of High-Frequency Deep Brain Stimulation for Treatment of Parkinson Disease: 2014 Lasker Award

Mahlon R. DeLong, MD; Alim-Louis Benabid, MD, PhD

Abstract Full Text

free access

JAMA. 2014;312(11):1093-1094. doi:10.1001/jama.2014.11132

This Viewpoint provides a summary of their discoveries in understanding the role of the basal ganglia in movement, in determining the neurophysiology of Parkinson disease, and in the development of deep brain stimulation.

The Ebola Epidemic: A Global Health Emergency

Lawrence O. Gostin, JD; Daniel Lucey, MD, MPH; Alexandra Phelan, LLM, BBiomedSc/LLB

Abstract Full Text

free access has audio

JAMA. 2014;312(11):1095-1096. doi:10.1001/jama.2014.11176

Podcast: The Ebola Epidemic: A Global Health Emergency

Quantifying a Nonnotifiable Disease in the United States: The National Amyotrophic Lateral Sclerosis Registry Model

D. Kevin Horton, DrPH, MSPH; Paul Mehta, MD; Vinicius C. Antao, MD, MSc, PhD

Abstract Full Text

JAMA. 2014;312(11):1097-1098. doi:10.1001/jama.2014.9799

A Piece of My Mind

Whose Autonomy?

Scott D. Stonington, MD, PhD

Abstract Full Text

JAMA. 2014;312(11):1099-1100. doi:10.1001/jama.2014.8273

Editorial

Treating COPD in the Real World

Peter M. A. Calverley, MBChB, DSc

Abstract Full Text

JAMA. 2014;312(11):1101-1102. doi:10.1001/jama.2014.11322

Child Health Theme Issue 2015: Call for Papers

Jody W. Zylke, MD

Abstract Full Text

free access

JAMA. 2014;312(11):1103-1104. doi:10.1001/jama.2014.10835

Care of the Aging Patient: From Evidence to Action

Evaluation and Treatment of Older Patients With Hypercholesterolemia: A Clinical Review

Timo E. Strandberg, MD, PhD; Laura Kolehmainen, MD, PhD; Alpo Vuorio, MD, PhD

Abstract Full Text

JAMA. 2014;312(11):1136-1144. doi:10.1001/jama.2014.10924

This Clinical Review reports that treatment of hypercholesterolemia for patients at risk for atherosclerotic cardiovascular disease should start before age 80 years.

From the 糖心vlog